SARS-CoV-2 vaccines are crucial in controlling COVID-19, but knowledge of which factors
determine waning immunity is limited. We examined antibody levels and T-cell gamma-…

The heterogeneity of the SARS-CoV-2 immune responses has become considerably more
complex over time and diverse immune imprinting is observed in vaccinated individuals. …

Globally, the COVID-19 pandemic has had extreme consequences for the healthcare
system and has led to calls for diagnostic tools to monitor and understand the transmission, …

The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to constitute a serious public …

Background Previous studies have indicated inferior responses to severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) vaccination in solid organ transplant (SOT) recipients…

Background People with HIV (PWH) are at increased risk of severe COVID‐19. We aimed to
determine humoral responses in PWH and controls who received two doses of BNT162b2. …

Background We investigated long-term durability of humoral and cellular immune responses
to third dose of BNT162b2 in people with HIV (PWH) and controls. Methods In 378 PWH …

Tools to monitor SARS-CoV-2 transmission and immune responses are needed. We present
a neutralization ELISA to determine the levels of Ab-mediated virus neutralization and a …

Introduction We investigated humoral and T-cell responses within 12 months after first
BNT162b2 vaccine in solid organ transplant (SOT) recipients and controls who had received at …

Background The durability of SARS‐CoV‐2 antibody response and the resulting immunity
to COVID‐19 is unclear. Objectives To investigate long‐term humoral immunity to SARS‐CoV‐…